Terry L. Poling

Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

Ana Strezova, Javier Díez‐Domingo, Kamal Al Shawafi et al. · Open Forum Infectious Diseases · 2022 · 101 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

Céline Boutry, Andrew Hastie, Javier Díez‐Domingo et al. · Clinical Infectious Diseases · 2021 · 93 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study

Joanne M. Langley, George Risi, Michael S. Caldwell et al. · The Journal of Infectious Diseases · 2011 · 80 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents

Germán Áñez, Lisa M. Dunkle, Cynthia L. Gay et al. · JAMA Network Open · 2023 · 50 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18–64 years of age

Geoffrey J. Gorse, Ann R. Falsey, John A. Fling et al. · Vaccine · 2013 · 35 citations

Veterinary Medicine, Immunology, Infectious Diseases +12